EFFECT OF RILMENIDINE, A CENTRALLY ACTING IMIDAZOLINE AGONIST ON THE RENIN-ANGIOTENSIN-ALDOSTERONE AND CATECHOLAMINE SYSTEM AND ON THE PARAMETERS INDICATING OXIDATIVE STRESS IN PATIENTS WITH ESSENTIAL HYPERTENSION: P2.119